As of 2025-10-21, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 452.94 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.61 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 6752.3%.
The range of the Relative Valuation is 316.77 - 612.47 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.4x - 41.0x | 34.2x |
| Forward P/E multiples | 21.3x - 31.7x | 26.5x |
| Fair Price | 316.77 - 612.47 | 452.94 |
| Upside | 4692.4% - 9165.9% | 6752.3% |
| Date | P/E |
| 2025-10-20 | 0.44 |
| 2025-10-17 | 0.44 |
| 2025-10-16 | 0.44 |
| 2025-10-15 | 0.45 |
| 2025-10-14 | 0.45 |
| 2025-10-13 | 0.45 |
| 2025-10-10 | 0.45 |
| 2025-10-09 | 0.46 |
| 2025-10-08 | 0.46 |
| 2025-10-07 | 0.46 |
| 2025-10-06 | 0.46 |
| 2025-10-03 | 0.46 |
| 2025-10-02 | 0.47 |
| 2025-10-01 | 0.46 |
| 2025-09-30 | 0.45 |
| 2025-09-29 | 0.45 |
| 2025-09-26 | 0.45 |
| 2025-09-25 | 0.45 |
| 2025-09-24 | 0.46 |
| 2025-09-23 | 0.46 |
| 2025-09-22 | 0.47 |
| 2025-09-19 | 0.47 |
| 2025-09-18 | 0.47 |
| 2025-09-17 | 0.46 |
| 2025-09-16 | 0.46 |
| 2025-09-15 | 0.46 |
| 2025-09-12 | 0.46 |
| 2025-09-11 | 0.47 |
| 2025-09-10 | 0.48 |
| 2025-09-09 | 0.48 |
| 2025-09-08 | 0.47 |
| 2025-09-05 | 0.47 |
| 2025-09-04 | 0.47 |
| 2025-09-03 | 0.47 |
| 2025-09-02 | 0.47 |
| 2025-08-29 | 0.47 |
| 2025-08-28 | 0.48 |
| 2025-08-27 | 0.48 |
| 2025-08-26 | 0.47 |
| 2025-08-25 | 0.46 |
| 2025-08-22 | 0.47 |
| 2025-08-21 | 0.47 |
| 2025-08-20 | 0.47 |
| 2025-08-19 | 0.48 |
| 2025-08-18 | 0.49 |
| 2025-08-15 | 0.48 |
| 2025-08-14 | 0.49 |
| 2025-08-13 | 0.50 |
| 2025-08-12 | 0.50 |
| 2025-08-11 | 0.49 |